(Q28217972)

2

0 references

S J Plummer

3

0 references

L M Krumroy

4

0 references

G Casey

5

0 references

J S Witte

British Journal of Cancer

6

0 references

language of work or name

English

0 references

publication date

20 August 2007

0 references

published in

0 references

volume

97

0 references

issue

4

0 references

page(s)

557-61

0 references

cites work

A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Nonsteroidal antiinflammatory drugs and decreased risk of advanced prostate cancer: modification by lymphotoxin alpha

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

A haplotype map of the human genome

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Efficiency and power in genetic association studies

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Genome-wide association studies for common diseases and complex traits

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

COX-2 gene promoter haplotypes and prostate cancer risk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

The role of cyclooxygenase-2 in prostate cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360347

Cyclooxygenase-2 promotes prostate cancer progression

2 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603874

Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603874

Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603874

Genetic variation in the COX-2 gene and the association with prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603874

Expression of cyclooxygenase-2 in prostate carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603874

Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603874

Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17609663

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17609663

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17609663